125 related articles for article (PubMed ID: 18242054)
21. Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol.
Pfeiler GH; Buechler C; Neumeier M; Schäffler A; Schmitz G; Ortmann O; Treeck O
Oncol Rep; 2008 Mar; 19(3):787-93. PubMed ID: 18288417
[TBL] [Abstract][Full Text] [Related]
22. [Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells].
Li X; Deng HY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):181-3. PubMed ID: 18630678
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between the expression of TrkB and anoikis resistance in nasopharyngeal carcinoma line].
Wen WS; Zhang Z; Xie Y; Yi X; Zhao WM; Xu ZW; Tang AZ; Huang GW
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 43(8):606-11. PubMed ID: 18959266
[TBL] [Abstract][Full Text] [Related]
25. Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells.
Kochetkova M; Kumar S; McColl SR
Cell Death Differ; 2009 May; 16(5):664-73. PubMed ID: 19136936
[TBL] [Abstract][Full Text] [Related]
26. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios.
Su CC; Lin YH
Int J Mol Med; 2008 Sep; 22(3):357-61. PubMed ID: 18698495
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells.
Nizamutdinova IT; Lee GW; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Int J Oncol; 2008 Sep; 33(3):485-91. PubMed ID: 18695877
[TBL] [Abstract][Full Text] [Related]
29. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis.
Galante JM; Mortenson MM; Bowles TL; Virudachalam S; Bold RJ
J Surg Res; 2009 Mar; 152(1):18-25. PubMed ID: 19062038
[TBL] [Abstract][Full Text] [Related]
30. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer.
So AI; Levitt RJ; Eigl B; Fazli L; Muramaki M; Leung S; Cheang MC; Nielsen TO; Gleave M; Pollak M
Clin Cancer Res; 2008 Nov; 14(21):6944-54. PubMed ID: 18980989
[TBL] [Abstract][Full Text] [Related]
32. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells.
Dos Santos E; Benaitreau D; Dieudonne MN; Leneveu MC; Serazin V; Giudicelli Y; Pecquery R
Oncol Rep; 2008 Oct; 20(4):971-7. PubMed ID: 18813842
[TBL] [Abstract][Full Text] [Related]
33. Involvement of reactive oxygen species/c-Jun NH(2)-terminal kinase pathway in kotomolide A induces apoptosis in human breast cancer cells.
Kuo PL; Chen CY; Tzeng TF; Lin CC; Hsu YL
Toxicol Appl Pharmacol; 2008 Jun; 229(2):215-26. PubMed ID: 18374381
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin.
Rohwer N; Welzel M; Daskalow K; Pfander D; Wiedenmann B; Detjen K; Cramer T
Cancer Res; 2008 Dec; 68(24):10113-20. PubMed ID: 19074877
[TBL] [Abstract][Full Text] [Related]
35. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
Perera CN; Chin HG; Duru N; Camarillo IG
J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
[TBL] [Abstract][Full Text] [Related]
36. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
37. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
Kanaan YM; Das JR; Bakare O; Enwerem NM; Berhe S; Beyene D; Williams V; Zhou Y; Copeland RL
Anticancer Res; 2009 Jan; 29(1):191-9. PubMed ID: 19331150
[TBL] [Abstract][Full Text] [Related]
38. Dieldrin initiates apoptosis in rat thymocytes.
Hallegue D; Ben Rhouma K; Krichah R; Sakly M
Indian J Exp Biol; 2002 Oct; 40(10):1147-50. PubMed ID: 12693695
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
[TBL] [Abstract][Full Text] [Related]
40. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.
Bocca C; Bozzo F; Martinasso G; Canuto RA; Miglietta A
Br J Nutr; 2008 Oct; 100(4):739-50. PubMed ID: 18304389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
